Drug Type Antibody |
Synonyms |
Target |
Mechanism Ang2 modulators(Angiopoietin-2 modulators), VEGF inhibitors(Vascular endothelial growth factor inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Eye Diseases | Preclinical | CN | 19 Aug 2024 |